Podcast
Questions and Answers
If a tolerogen's molecular form is altered, what immunological outcome is most likely to occur?
If a tolerogen's molecular form is altered, what immunological outcome is most likely to occur?
- It will be recognized as a superantigen, leading to a cytokine storm.
- It will be degraded into smaller peptides, preventing any immune recognition.
- It can transform into an immunogen, capable of eliciting an immune response. (correct)
- It will continue to induce a state of immune non-responsiveness, ensuring tolerance is maintained.
Which characteristic of an antigen is most crucial for initiating a vigorous and effective adaptive immune response?
Which characteristic of an antigen is most crucial for initiating a vigorous and effective adaptive immune response?
- Its foreignness and high molecular weight, distinguishing it from self-components. (correct)
- Its small size, allowing for easier processing by immune cells.
- Its high degree of similarity to self-proteins, minimizing the risk of autoimmunity.
- Its ability to be rapidly cleared from the body to prevent overstimulation.
How do superantigens bypass the typical requirements of antigen processing and presentation in T cell activation?
How do superantigens bypass the typical requirements of antigen processing and presentation in T cell activation?
- By exclusively activating B cells, leading to indirect T cell activation.
- By forming a trimolecular complex outside the typical antigen-binding groove of MHC molecules. (correct)
- By directly binding to the T cell receptor (TCR) without MHC involvement.
- By being processed and presented by MHC class II molecules in a conventional manner.
What is the primary distinction between linear and conformational epitopes in terms of structural dependency?
What is the primary distinction between linear and conformational epitopes in terms of structural dependency?
Considering both antigenicity and immunogenicity, what is a key difference between a complete antigen and an incomplete antigen (hapten)?
Considering both antigenicity and immunogenicity, what is a key difference between a complete antigen and an incomplete antigen (hapten)?
How does the route of administration affect the immunogenicity of an antigen, and why?
How does the route of administration affect the immunogenicity of an antigen, and why?
What is the implication of an autoantigen being recognized by the immune system in the context of autoimmune disease?
What is the implication of an autoantigen being recognized by the immune system in the context of autoimmune disease?
In the context of epitope recognition, what best describes the interaction between an epitope and a paratope?
In the context of epitope recognition, what best describes the interaction between an epitope and a paratope?
How does somatic recombination contribute to antibody diversity, and why is this diversity important for adaptive immunity?
How does somatic recombination contribute to antibody diversity, and why is this diversity important for adaptive immunity?
Which of the following scenarios best describes the role of adjuvants in vaccination?
Which of the following scenarios best describes the role of adjuvants in vaccination?
How does the phenomenon of 'original antigenic sin' potentially impact an individual's response to subsequent viral infections, such as influenza?
How does the phenomenon of 'original antigenic sin' potentially impact an individual's response to subsequent viral infections, such as influenza?
If a patient lacks a thymus, what type of antigen would they have the most difficulty responding to, and why?
If a patient lacks a thymus, what type of antigen would they have the most difficulty responding to, and why?
What is the functional consequence of antibodies undergoing affinity maturation during a prolonged immune response?
What is the functional consequence of antibodies undergoing affinity maturation during a prolonged immune response?
How do heterophilic antigens challenge the specificity principle of immune responses?
How do heterophilic antigens challenge the specificity principle of immune responses?
If a tumor cell only presents tumor-specific antigens (TSAs) via MHC class I molecules, what immunological outcome is most likely to occur?
If a tumor cell only presents tumor-specific antigens (TSAs) via MHC class I molecules, what immunological outcome is most likely to occur?
What mechanism explains why antibodies, despite not directly destroying antigens, are effective in combating infections?
What mechanism explains why antibodies, despite not directly destroying antigens, are effective in combating infections?
How might understanding the principles of antibody diversity and somatic hypermutation be applied to improve vaccine design?
How might understanding the principles of antibody diversity and somatic hypermutation be applied to improve vaccine design?
What is the significance of the 'hinge region' in the structure of an IgG antibody molecule?
What is the significance of the 'hinge region' in the structure of an IgG antibody molecule?
Considering the different antibody isotypes(IgM, IgG, IgA, IgE, IgD), what best defines isotype switching and its functional importance?
Considering the different antibody isotypes(IgM, IgG, IgA, IgE, IgD), what best defines isotype switching and its functional importance?
How does complement fixation by antibodies lead to enhanced pathogen clearance and inflammation?
How does complement fixation by antibodies lead to enhanced pathogen clearance and inflammation?
How does the concept of 'avidity' differ from 'affinity' in the context of antibody-antigen interactions, and what is its functional significance?
How does the concept of 'avidity' differ from 'affinity' in the context of antibody-antigen interactions, and what is its functional significance?
Which physical forces play a crucial role in holding antibodies and antigens together and how do these forces contribute to the overall stability of the interaction?
Which physical forces play a crucial role in holding antibodies and antigens together and how do these forces contribute to the overall stability of the interaction?
How do mitogens differ from conventional antigens in their ability to activate T cells, and what are the potential consequences of this difference?
How do mitogens differ from conventional antigens in their ability to activate T cells, and what are the potential consequences of this difference?
Under what circumstances might an allogenic antigen trigger an immune response, and what is the underlying mechanism for this response?
Under what circumstances might an allogenic antigen trigger an immune response, and what is the underlying mechanism for this response?
Why is degradability considered an important property of antigens in the context of adaptive immune responses?
Why is degradability considered an important property of antigens in the context of adaptive immune responses?
How does the structure of IgM contribute to its high avidity, particularly in early immune responses?
How does the structure of IgM contribute to its high avidity, particularly in early immune responses?
What is the role of the polymeric Ig receptor (pIgR) in the transport and function of IgA antibodies, especially at mucosal surfaces?
What is the role of the polymeric Ig receptor (pIgR) in the transport and function of IgA antibodies, especially at mucosal surfaces?
How do idiotypic antigens contribute to the regulation of the immune response, and what is their potential therapeutic application?
How do idiotypic antigens contribute to the regulation of the immune response, and what is their potential therapeutic application?
How does the presence or absence of a thymus influence the development and function of T cell epitopes?
How does the presence or absence of a thymus influence the development and function of T cell epitopes?
What accounts for the structural diversity in the variable regions of antibody molecules?
What accounts for the structural diversity in the variable regions of antibody molecules?
How does the interaction between antibodies and antigens lead to the neutralization of pathogens or toxins?
How does the interaction between antibodies and antigens lead to the neutralization of pathogens or toxins?
What distinguishes anaphylatoxins (such as C3a and C5a) from other complement components, and how do they contribute to the inflammatory response?
What distinguishes anaphylatoxins (such as C3a and C5a) from other complement components, and how do they contribute to the inflammatory response?
How does precipitation differ from agglutination as a mechanism of antibody action, and what is the practical significance of this difference?
How does precipitation differ from agglutination as a mechanism of antibody action, and what is the practical significance of this difference?
What role do framework regions play in antibody structure and function, and how do they differ from hypervariable regions?
What role do framework regions play in antibody structure and function, and how do they differ from hypervariable regions?
Which statement correctly differentiates between heterophilic, xenogeneic, and allogeneic antigens?
Which statement correctly differentiates between heterophilic, xenogeneic, and allogeneic antigens?
Why is it critical for tumor-specific antigens (TSAs) to be presented by MHC class I molecules on tumor cells for effective anti-tumor immunity?
Why is it critical for tumor-specific antigens (TSAs) to be presented by MHC class I molecules on tumor cells for effective anti-tumor immunity?
Flashcards
Antigen
Antigen
Substances that induce a specific immune response and react with the products of that response.
Antigen (simple)
Antigen (simple)
A molecule that stimulates an immune response.
Tolerogen
Tolerogen
An antigen that invokes a specific immune non-responsiveness due to its molecular form. It can become immunogen when modified.
Allergen
Allergen
Signup and view all the flashcards
Exogenous antigens
Exogenous antigens
Signup and view all the flashcards
Endogenous antigens
Endogenous antigens
Signup and view all the flashcards
Autoantigens
Autoantigens
Signup and view all the flashcards
Tumor antigens
Tumor antigens
Signup and view all the flashcards
Immunogenicity
Immunogenicity
Signup and view all the flashcards
Antigenicity
Antigenicity
Signup and view all the flashcards
Complete antigen
Complete antigen
Signup and view all the flashcards
Incomplete antigen (hapten)
Incomplete antigen (hapten)
Signup and view all the flashcards
Epitope (Antigenic determinants)
Epitope (Antigenic determinants)
Signup and view all the flashcards
Linear epitopes
Linear epitopes
Signup and view all the flashcards
Conformational epitopes
Conformational epitopes
Signup and view all the flashcards
B cell epitope
B cell epitope
Signup and view all the flashcards
T cell epitope
T cell epitope
Signup and view all the flashcards
Superantigen
Superantigen
Signup and view all the flashcards
Mitogen
Mitogen
Signup and view all the flashcards
Adjuvant
Adjuvant
Signup and view all the flashcards
Heterophilic antigen
Heterophilic antigen
Signup and view all the flashcards
Xenogenic antigen
Xenogenic antigen
Signup and view all the flashcards
Allogenic antigen
Allogenic antigen
Signup and view all the flashcards
Autoantigen
Autoantigen
Signup and view all the flashcards
Idiotypic antigen
Idiotypic antigen
Signup and view all the flashcards
Immunogenicity (protein size)
Immunogenicity (protein size)
Signup and view all the flashcards
Immunogenicity (dosage)
Immunogenicity (dosage)
Signup and view all the flashcards
Immunogenicity (route)
Immunogenicity (route)
Signup and view all the flashcards
Immunogenicity (composition)
Immunogenicity (composition)
Signup and view all the flashcards
Immunogenicity (form)
Immunogenicity (form)
Signup and view all the flashcards
Immunogenicity (similarity)
Immunogenicity (similarity)
Signup and view all the flashcards
Immunogenicity (adjuvants)
Immunogenicity (adjuvants)
Signup and view all the flashcards
Immunogenicity (Interaction)
Immunogenicity (Interaction)
Signup and view all the flashcards
Affinity
Affinity
Signup and view all the flashcards
Avidity
Avidity
Signup and view all the flashcards
Isotypes
Isotypes
Signup and view all the flashcards
Allotypes
Allotypes
Signup and view all the flashcards
Idiotypes
Idiotypes
Signup and view all the flashcards
Study Notes
Concept of Antigens
- Antigens are substances inducing specific immune responses, reacting with the products of those responses
- The term "antigen" originally meant substances stimulating antibody generation
- The immune system consists of more than just antibodies
- The modern definition of antigen includes all substances recognizable by the adaptive immune system
Tolerogens
- Tolerogens are antigens inducing specific immune non-responsiveness based on their molecular form
- A tolerogen can become an immunogen if its molecular form is altered
Allergens
- Allergens induce allergic reactions
- Allergic reactions can occur after exposure through ingestion, inhalation, injection, or skin contact
Classification of Antigens by Origin
- Antigens can be classified based on their origin
Exogenous Antigens
- Exogenous antigens enter the body from the outside via inhalation, ingestion, or injection
- These antigens are taken into antigen-presenting cells (APCs) through endocytosis or phagocytosis, and then processed into fragments
Endogenous Antigens
- Endogenous antigens are generated within cells due to normal metabolism, viral infections, or intracellular bacterial infections
Autoantigens
- Autoantigens are typically normal proteins or protein complexes (sometimes DNA or RNA) recognized by the immune system in patients with autoimmune diseases
- These antigens do not usually trigger an immune response, but genetic or environmental factors can cause a loss of immunological tolerance
Tumor Antigens
- Tumor antigens are presented by MHC I molecules on tumor cell surfaces
- Tumor-specific antigens (TSAs) are only presented by tumor cells and result from tumor-specific mutations
Characteristics of Antigens
- Immunogenicity: The capacity to stimulate antibody production or cell-mediated immune responses
- Antigenicity: The ability to bind to an antibody
Complete vs Incomplete Antigens
- Complete antigens can induce an immune response and bind to antibodies
- Incomplete antigens have antigenic determinants but cannot induce immune responses because they lack necessary attributes
- Haptens are examples of incomplete antigens
Properties of Antigens
- Foreignness
- Specificity
- High molecular weight, ideally > 750 Da
- Structural stability
- Degradability
- Route of administration
- Host genetics
- Dosage
Antigenic Epitopes
- Epitopes (antigenic determinants) are portions of antigen molecules that physically interact with paratopes on immune response molecules
- Epitopes determine antigen specificity
Types of Epitopes
Linear Epitopes
- Linear epitopes are continuous and found in polysaccharides as well as native and denatured proteins
- Specificity relies on the primary sequence
- Typical length is 5-6 subunits
Conformational Epitopes
- Conformational epitopes are discontinuous, involving multiple subunits far apart in the primary sequence
- They are only found in native globular proteins
- Specificity depends on conformation (3D shape from tertiary and quaternary structures)
- Sequences of up to 16 amino acids in certain protein antigens have been shown to interact with paratope
B Cell and T Cell Epitopes
- B cell epitopes are portions of antigen molecules recognized by B cell receptors
- T cell epitopes are regions of antigen molecules recognized by T cell receptors
Classification of Antigens
- Thymus-dependent antigens (TD-Ag)
- Thymus-independent antigens (TI-Ag)
Superantigens
- Superantigens are potent T lymphocyte mitogens that bind to class II MHC molecules
- They are associated with staphylococcal products, potentially causing enterotoxemias and toxic shock syndrome
- Superantigens (SAgs) are secreted proteins (exotoxins) with high mitogenic activity towards T lymphocytes
- SAgs activate up to 20% of the body's T-cells, compared to 0.001-0.0001% in a normal antigen-induced response
- This causes a non-specific massive immune response
Mitogens
- Mitogens induce mitosis
- Mitogens activate T and/or B cells without help from APCs
- Examples include Lectin (concanavalin A), LPS (lipopolysaccharide), and Staphylococcal protein A (SPA)
Adjuvants
- Adjuvants, from Latin "adjuvans" meaning "to help"
- Adjuvants enhance the pharmacological effect of drugs or increase an antigen's ability to stimulate the immune system
Classification of Adjuvants
- Freund’s adjuvant: Complete Freund's adjuvant (CFA) and Incomplete Freund’s adjuvant (IFA)
- Liposome
- Inorganic compound
- Cytokine
- Biodegradable nanoparticles
Mechanisms of Adjuvants
- Prolonged persistence of immunogen molecules at the injection site
- Enhancement of co-stimulatory signals
- Induction of granuloma formation
- Stimulation of lymphocyte proliferation in a non-specific manner
Other Antigens
- Heterophilic antigen: Common antigen existing in humans, animals, and microbes; e.g., Fossman antigen
- Xenogenic antigen: from a different genus and generic; e.g., pathogenic antigen
- Allogenic antigen: Exists in different individuals; e.g., blood type antigens
- Autoantigen: A pathological term; e.g., sperm antigen
- Idiotypic antigen: An antibody molecule recognized as an antigen by the immune system
Antibodies
- Antibodies are also termed Immunoglobulins
- Antibodies are globulin (gamma) fractions of serum proteins
- Antibodies are generated by the immune system against specific foreign antigens
- Antibodies are a main component of Humoral Immunity (HI)
- Rodney Porter described the structure of antibody molecules and received the Nobel Prize in 1972
Immunoglobulin Classes
- IgM: μ (mu) heavy chains, κ (kappa) or λ (lambda) light chains
- IgG: γ (gamma) heavy chains, κ (kappa) or λ (lambda) light chains
- IgA: α (alpha) heavy chains, κ (kappa) or λ (lambda) light chains
- IgE: ε (epsilon) heavy chains, κ (kappa) or λ (lambda) light chains
- IgD: δ (delta) heavy chains, κ (kappa) or λ (lambda) light chains
Major Immunoglobulin Class Properties
- IgG: 160 kDa, 3% carbohydrate, γ electrophoretic mobility, 4 heavy chain domains, 4 subclasses, 21 day half life, 2 antigen binding valency
- IgM: 900 kDa, 12% carbohydrate, β electrophoretic mobility, 5 heavy chain domains, no subclasses, 5 day half life, 5(10) antigen binding valency
- IgA: 360 kDa, 7% carbohydrate, β-γ electrophoretic mobility, 4 heavy chain domains, 2 subclasses, 6 day half life, 2,4 antigen binding valency
- IgE: 200 kDa, 12% carbohydrate, β-γ electrophoretic mobility, 5 heavy chain domains, no subclasses, 2 day half life, 2 antigen binding valency
- IgD: 160-180 kDa, 12% carbohydrate, γ electrophoretic mobility, 4 heavy chain domains, no subclasses, 3 day half life, 2 antigen binding valency
Immunoglobulin Structure
- Each light chain contains about 214 amino acids in two domains
- Heavy chains of IgG contain about 445 amino acids in 4 domains
- The variation in amino acid sequence is largely restricted to three smaller regions within the entire variable region, these regions are known as hypervariable regions
- Between the hypervariable regions, the amino acid sequences are relatively constant and termed as framework regions
- The hinge region consists of about 12 amino acids located between CH1 and CH2 domains, is rich in hydrophilic and proline residues making the region flexible and accessible to proteolytic enzymes and contains all the interchain disulfide bonds
IgG Properties
- IgG has a molecular weight of 160 kDa
- IgG is secreted as a secondary antibody
- IgG is the major secretory antibody in animals
- IgG is found in the highest concentration in blood
- IgG includes the subclasses IgG1, IgG2, IgG3, and IgG4
IgM Properties
- IgM is a pentamer
- IgM is the primary immunoglobulin
- IgM is available as a second-highest concentration in mammalian serum
- All monomers are bound by a cysteine-rich polypeptide called the J-chain (15 kDa) binding two of the units to complete the circle
- The heavy chain of IgM molecules contains an additional CH4 domain
IgA Properties
- IgA is a major secretory antibody of non-ruminants
- IgA produced on body surfaces can pass through epithelial cells into external secretions or diffuse into the bloodstream
- Most IgA in the intestinal wall is carried into the intestinal fluid
- IgA is transported through intestinal epithelial cells to polymeric Ig receptor (plgR), or secretory component- a 71 kDa receptor
- Secretory components bind covalently to IgA dimers forming secretory IgA (SIgA), protecting IgA from digestion by intestinal proteases
IgE and IgD Properties
- IgE is a monomer with an extra CH4 domain in its heavy chains
- IgE is largely responsible for immunity against parasitic worms and Type-I hypersensitivity reactions
- IgE molecules are generally found bound to the surface of mast cells and basophils
- IgD is primarily a B cell receptor
- IgD molecules don't have a CH2 domain; the CH1 and CH3 domains are separated by a long exposed hinge region
- Because it does not have disulfide bonds, IgD is highly susceptible to proteolytic enzymes
Immunoglobulin Variation
- Isotypes: Structural variations in Ig classes that occur in all animals of a species; also called classes
- Allotypes: Minor inherited sequence variations between proteins of different individuals
- Idiotopes: Unique structural variations in antigen-binding proteins such as Igs and TCRs, formed by variable regions on light and heavy chains; collectively known as isotypes
Affinity and Avidity
- Affinity: The tightness of antigen binding site attachment to an antigen determinant (epitope)
- Avidity: The tightness of binding when several antigen binding sites attach to several antigenic determinants
Mechanisms of Antibody Diversity
- Plasma cells make over a billion different types of antibodies
- Each cell contains 100,000 gene coding polypeptides
- Somatic recombination takes place to code for the many antibodies
- Gene segments are shuffled and recombined ways by B cells as these become immunocompetent
- Information of the newly assembled genes is expressed as B cell receptors and antibodies
Antibody Diversity
- Random mixing of gene segments creates unique antibody genes
- Genes encode for H and L chains and account for the variability in antibodies
- V gene segments, called hypervariable regions, mutate and increase antibody variation
- Plasma cells can switch H chains, making two or more classes with the same V region
Antibody Targets
- Antibodies themselves do not directly destroy antigens, they inactivate and tag for destruction
- Antibodies form antigen-antibody (immune) complexes
- Defensive mechanisms used by antibodies include neutralization, agglutination, precipitation, and complement fixation
Complement Fixation and Activation
- Complement fixation is the main mechanism used against cellular antigens
- Antibodies bound to cells change shape and expose complement binding sites
- This triggers complement fixation and cell lysis
- Complement activation enhances the inflammatory response, uses a positive feedback cycle to promote phagocytosis, and enlists more defensive elements
Other Mechanisms of Antibody Action
- Neutralization: Antibodies bind to and block specific sites on viruses or exotoxins
- Agglutination: Antibodies bind the same determinant on more than one antigen, forming cross-linked antigen-antibody complexes
- Cell-bound antigens are cross-linked, causing clumping (agglutination)
- Precipitation: Soluble molecules are cross-linked into large insoluble complexes
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.